BIO-key International (NASDAQ:BKYI) Stock Moved Down to “Sell” by Wall Street Zen

BIO-key International (NASDAQ:BKYI) was downgraded by investment analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued on Saturday, Wall Street Zen reports.

BKYI has been the subject of several other research reports. Zacks Research raised BIO-key International to a “hold” rating in a research report on Thursday, August 6th. Weiss Ratings reissued a “sell (e+)” rating on shares of BIO-key International in a research note on Thursday, October 15th. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Reduce”.

BIO-key International Stock Performance

Shares of BKYI stock opened at $2.12 on Friday. The stock has a fifty day moving average price of $2.46 and a 200 day moving average price of $4.40. The stock has a market cap of $4.31 million, a PE ratio of -0.52 and a beta of 0.52. BIO-key International has a 1 year low of $1.55 and a 1 year high of $10.70.

BIO-key International (NASDAQ:BKYI) last issued its quarterly earnings data on Friday, November 13th. The technology company reported ($4.01) EPS for the quarter, missing analysts’ consensus estimates of ($0.35) by ($3.66). The business had revenue of $1.48 million during the quarter, compared to analyst estimates of $2.40 million. BIO-key International had a negative net margin of 50.01% and a negative return on equity of 67.31%. As a group, equities research analysts predict that BIO-key International will post -1.62 earnings per share for the current year.

About BIO-key International

BIO-key International, Inc. (NASDAQ: BKYI) develops biometric authentication and identity and access management solutions. The company helps organizations secure access to applications, networks, devices and data through fingerprint recognition and other authentication methods designed to reduce reliance on passwords. Its product portfolio includes PortalGuard, an identity and access management platform that supports single sign-on, multifactor authentication, self-service password management and access control.